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Abstract 
S-Acylation is a major post-translational modification, catalysed by the zDHHC enzyme family. S-acylated proteins can be 
modified by different fatty acids; however, very little is known about how zDHHC enzymes contribute to acyl chain 
heterogeneity. Here, we employed fatty acid azide/alkyne labelling of mammalian cells, showing their transformation into acyl-
CoAs and subsequent click chemistry-based detection, to demonstrate that zDHHC enzymes have marked differences in their 
fatty acid selectivity. This was apparent even for highly related enzymes such as zDHHC3 and zDHHC7, which displayed a marked 
difference in ability to use C18:0 acyl CoA as a substrate. Furthermore, we identified Isoleucine-182 in the third transmembrane 
domain of zDHHC3 as a key determinant limiting the use of longer chain acyl-CoAs by this enzyme. This is the first study to 
uncover differences in the fatty acid selectivity profiles of cellular zDHHC enzymes and to map molecular determinants governing 
this selectivity.  
 
Significance Statement 
S-Acylation, the attachment of different fatty acids onto cysteine residues, regulates the activity of a diverse array of 
cellular proteins. This reversible post-translational modification is essential for normal physiology and defects are linked 
to human disease. S-ĂĐǇůĂƚŝŽŶŝƐĐĂƚĂůǇƐĞĚďǇĂůĂƌŐĞĨĂŵŝůǇŽĨ “ǌ,, ?-^acyltransferases that use a cellular pool of 
diverse fatty acyl CoAs as substrates. Using chemically-synthesised probes, we show that individual zDHHC enzymes 
have marked differences in fatty acid selectivity, and identify the underlying molecular basis for this. The study describes 
how acyl chain heterogeneity of S-acylated proteins is generated, and is significant because the chemical nature of the 
attached S-acyl chain can fundamentally impact protein behaviour. 
\body 
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Introduction 
S-Acylation is a reversible post-translational modification 
(PTM) involving the attachment of fatty acids onto 
cysteines(1, 2). This PTM occurs on both soluble and 
transmembrane (TM) proteins and exerts a number of 
important effects, such as mediating membrane binding (of 
soluble proteins or soluble loops of TM proteins), regulating 
protein trafficking and targeting to cholesterol-rich 
membrane micro-domains, and modulating protein 
stability(3, 4). These actions of S-acylation on a diverse array 
of cellular proteins impact many important physiological 
pathways, and defects in this process are linked to a number 
of major diseases and disorders(2, 5). 
S-Acylation is mediated by the opposing actions of 
acyltransferases and thioesterases. S-Acyltransferase 
enzymes belong to the zDHHC protein family, which are 
encoded by twenty-four distinct genes(6-8). zDHHC enzymes 
are thought to share the same overall membrane topology, 
with 4-6 transmembrane domains and the N- and C-termini 
present in the cytosol(9). The catalytic DHHC cysteine-rich 
domain (CRD) of the enzymes lies in a cytosolic loop(9) 
allowing zDHHC enzymes to modify substrate cysteines 
present at the cytosol-membrane interface. The S-acylation 
reaction is thought to proceed through an enzyme-acyl 
intermediate, where the acyl chain is attached to the cysteine 
of the DHHC motif via a thioester linkage (often referred to as 
ĞŶǌǇŵĞ  “ĂƵƚŽĂĐǇůĂƚŝŽŶ ? ?(10, 11). The S-acyl chain is then 
transferred to a cysteine residue of a substrate protein(10, 
11) ? dŚŝƐ ŽǀĞƌĂůů ƉƌŽĐĞƐƐ ŝƐ ƌĞĨĞƌƌĞĚ ƚŽ ĂƐ Ă  “ƉŝŶŐ-ƉŽŶŐ ?
reaction mechanism. There has been progress identifying the 
zDHHC enzymes that are active against many substrate 
proteins(2), although we lack a detailed understanding of the 
protein substrate profiles of individual enzymes and how 
enzyme-substrate interaction specificity is achieved. Co-
expression experiments have suggested that individual 
zDHHC enzymes might exhibit a level of overlap in their 
protein substrate profiles, suggesting some possible 
redundancy within the zDHHC family(2). Nevertheless, 
individual enzymes have been linked with many disorders, 
including intellectual disability, diabetes and cancer, 
suggesting that any functional redundancy is limited(2). 
In contrast to the steadily increasing knowledge about the 
specific interactions of zDHHC enzymes with their protein 
substrates, we know relatively little about the fatty acid 
selectivity of these enzymes. The term palmitoylation is often 
used as a synonym for S-acylation. However this does not 
reflect the potential diversity of S-acyl chains added to 
substrate proteins. Indeed, an analysis of the acyl groups 
added to S-acylated proteins in platelets revealed that 74% 
were from palmitate (C16:0), 22% from stearate (C18:0) and 
4% from oleate (C18:1)(12). Other studies have shown that S-
acylated proteins can be modified by acyl chains from 
myristic acid (C14:0), palmitoleic acid (C16:1), linoleic acid 
(C18:2) and arachidonic acid (C20:4)(12-15). Furthermore, 
mass spectrometry analysis of the S-acyl chains attached to 
influenza haemagglutinin proteins has revealed that C16:0 
and C18:0 fatty acids are attached in a site-specific 
manner(16). There is also potential for cell type specific 
differences in the fatty acid profiles of S-acylated proteins; for 
example, one study reported that in RAW26.7 cells less than 
10% of the acyl-CoAs were greater than C20, whereas in 
MCF7 cells C24:0 and C26:0 acyl-CoAs were present at similar 
amounts to C16:0 and C18:0 acyl-CoAs(17). The identity of 
the added acyl chain is central to the regulatory effects of S-
acylation as different acyl chains vary in affinity for 
membranes and for cholesterol-rich membrane micro-
domains(18). 
To-date, a single study has explored the potential role of 
zDHHC enzymes in differential protein S-acylation using 
purified recombinant zDHHC enzymes in detergent 
micelles(10). This study reported that zDHHC2 catalysed the 
S-acylation of substrate proteins with similar efficiency using 
palmitate (C16:0), stearate (C18:0) or C20 (C20:0, C20:4) fatty 
acids. In contrast, zDHHC3 displayed a marked preference for 
shorter chain length acyl-CoAs and incorporated C16:0 much 
more efficiently than either C18:0 or C20 fatty acids(10). This 
elegant study highlighted the potential for discrete patterns 
of fatty acid selectivity in the zDHHC family, but these 
questions have been challenging to address, particularly in a 
cellular context. Recent developments at the chemistry-
biology interface have identified new approaches to 
investigate this poorly defined area of the S-acylation field. 
Specifically, azide and alkyne fatty acid probes have provided 
novel and highly-sensitive chemical tools to interrogate S-
acylation by click chemistry(19-24). In this study, we report 
the use of chemically-synthesised azide and alkyne fatty acid 
probes to investigate fatty acid selectivity in the zDHHC 
enzyme family and determine the molecular mechanisms 
governing this selectivity. 
Results 
Azide fatty acids are good mimics of endogenous fatty acids   
Fatty acid azide probes of different acyl chain length were 
synthesised as described in the SI Appendix. To assess their 
ability to be taken up by cells, the total fatty acid content of 
HEK293T cells treated with these synthesised azide fatty acids 
was determined (Figure 1). Untreated cells showed the 
expected range of saturated and unsaturated fatty acids, with 
C18:0 and C18:1 being the most abundant. Upon addition of 
the various azide fatty acids to the cells, it can clearly be seen 
that these were not only accumulated within the cells (with 
C16:0 and C18:0 azides being taken up significantly better 
than C14:0 and C20:0 azides), but also metabolised by the 
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cells. For example the C16:0 azide was elongated to C18:0, 
which was subsequently desaturated to C18:1, while the 
added C18:0 azide was also desaturated to C18:1 and to a 
very minor extent C18:2. However, C18:0 azide was not 
significantly elongated to C20:0.  
As S-acylation of proteins involves acyl-CoA donors, it was 
deemed important that the impact on the cellular acyl-CoA 
pools be determined. This was achieved using a multiple 
reaction monitoring mass spectrometric method in 
conjunction with an internal non-natural (C17:0) acyl-CoA 
standard. This analysis revealed that in the untreated 
HEK293T cells, the C18:1- and C16:0-CoA were the most 
abundant, accounting for almost half of the total acyl-CoA 
pool (Figure 2). Upon addition of the various azide fatty acids, 
a significant amount of the corresponding acyl-CoA azides 
were formed, including some of the corresponding 
metabolised (elongated and desaturated) acyl-CoAs azides, 
reflecting the total fatty acid content. It is interesting to note 
that there were decreases in the corresponding endogenous 
acyl-CoA pools, suggesting clear competition for the acyl-CoA 
synthases that have a preference for particular acyl chain 
length. 
Collectively, these data strongly suggest that the synthesised 
azide fatty acids are good mimics of the natural saturated 
fatty acids and can be used for downstream metabolic 
processes involving fatty acids, such as lipid metabolism and 
protein lipidation. 
zDHHC enzymes display marked differences in fatty acid 
azide selectivity in cell-based substrate S-acylation assays 
To test the ability of the synthesised azide fatty acid probes 
to reliably measure protein S-acylation, HEK293T cells were 
co-transfected with EGFP-SNAP25b and HA-zDHHC3 or an 
inactive mutant of this enzyme (C157S). Figure 3A shows that 
zDHHC3 promoted a marked increase in incorporation of the 
azide probes into SNAP25, whereas in the absence of active 
enzyme (either empty vector or the C157S mutant) only a low 
signal was detected, presumably representing SNAP25 that is 
modified by endogenously-expressed zDHHC enzymes. To 
test if the incorporated azide probes were attached to 
SNAP25 via a thioester linkage, transfected cells were treated 
overnight with 1M hydroxylamine (HA) pH 7, which led to a 
marked loss of labelling, whereas incubation with 1M Tris (pH 
7) as a control had no effect (Figure 3B). 
The results presented in Figure 3 suggest that the level of 
C18:0 incorporation into SNAP25 by zDHHC3 is markedly 
lower than C14:0 and C16:0. Our previous work and others ? 
has shown that five zDHHC enzymes are active against 
SNAP25 in similar co-expression assays: zDHHC2, zDHHC3, 
zDHHC7, zDHHC15 and zDHHC17(25). Thus, we undertook a 
quantitative comparison of SNAP25 S-acylation by these five 
zDHHC enzymes to examine for the first time if zDHHC 
enzymes exhibit any differences in fatty acid selectivity when 
expressed in cells. The results shown in Figure 4A (top left 
panel) confirm that zDHHC3 has a marked preference for 
C14:0/C16:0 over C18:0-azide. Interestingly, zDHHC7 which is 
highly related to zDHHC3 at sequence level (67.8% identical 
for mouse) incorporated C18:0-azide into SNAP25 more 
efficiently than zDHHC3 did, although there was still a 
significant reduction in C18:0-azide incorporation relative to 
C14:0/C16:0 azides with this enzyme (Figure 4A, top panel). 
zDHHC2 and zDHHC15, also displayed interesting differences 
in fatty acid azide selectivity despite being highly related at 
amino acid level (65.4% identical): zDHHC2 exhibited no 
significant preference whereas C18:0 incorporation into 
SNAP25 by zDHHC15 was markedly lower than C14:0/C16:0 
azides (Figure 4A, middle panel). Finally, zDHHC17 showed a 
preference for longer chain fatty acids and incorporated 
C16:0 and C18:0 with higher efficiency than C14:0 (Figure 4A, 
bottom right panel). We also synthesised the corresponding 
alkyne probes and assayed their incorporation into SNAP25 
by zDHHC-3, -7 and -17, which revealed the same distinct 
profiles as seen with the azide probes (Figure 4B). To avoid 
confusion, the number of carbon groups given in the name 
for the alkyne probes reflects those of the fatty acid minus 
the alkyne group. Thus, C14:0-alkyne is a C14 fatty acid chain 
plus an alkyne group (16 carbon atoms total). Synthesis of 
these alkyne probes and their correct IUPAC nomenclature is 
given in the SI Appendix. 
To generate a more comprehensive understanding of the 
limits of zDHHC fatty acid selectivity, we also examined C20:0 
and C22:0 azide probes. zDHHC3 showed no difference in 
ability to transfer C18:0, C20:0 or C22:0 (low incorporation 
for each), whereas zDHHC7 and zDHHC17 displayed a gradual 
decline in azide incorporation as chain length was increased 
(Figure 5A). We also used competition assays to test the 
ability of unlabelled fatty acids to block C16:0 azide 
incorporation into SNAP25 by zDHHC3 and zDHHC17. 
Consistent with the observation that zDHHC3 did not 
incorporate the C18:0 azide probe with high efficiency, 
neither stearic acid (C18:0) nor oleic acid (C18:1) could block 
incorporation of C16:0 azide into SNAP25 catalysed by this 
enzyme, whereas myristic acid (C14:0), palmitic acid (C16:0) 
and palmitoleic acid (C16:1) were all effective inhibitors 
(Figure 5B). In contrast to zDHHC3, stearic acid effectively 
blocked C16:0 azide incorporation into SNAP25 by zDHHC17, 
whereas myristic acid and palmitic acid had no significant 
inhibitory effect (Figure 5B). Furthermore, oleic acid and 
linoleic acid (C18:2) also blocked incorporation of C16:0 
azide, and indeed even arachidonic acid (C20:4) was effective 
at blocking C16:0 azide incorporation by zDHHC17 (Figure 
5B). The inhibitory effects of these longer chain unsaturated 
fatty acids are interesting given that significant amounts of 
the respective acyl CoAs are present in HEK293T cells (Figure 
2). In contrast, lignoceric acid (C24:0) did not inhibit C16:0 
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azide incorporation, consistent with the results presented in 
Figure 5A showing that C22:0 azide displayed a marked 
reduction in incorporation by zDHHC17 compared with 
shorter chain azide probes. Autoacylation of all zDHHC 
enzymes tested was dependent on an intact DHHC motif (SI 
Appendix, Supplementary Figure 1). 
Different fatty acid selectivities of zDHHC enzymes 
correspond to autoacylation status 
The S-acylation reaction proceeds via an enzyme-acyl 
intermediate  ?ƌĞĨĞƌƌĞĚƚŽĂƐ “ĂƵƚŽĂĐǇůĂƚŝŽŶ ? ?ĂŶĚ is followed 
by transfer of the acyl chain to a substrate protein(10). We 
therefore tested if the different substrate S-acylation profiles 
observed in Figures 4 and 5 correspond with the 
autoacylation status of zDHHC enzymes. Figure 6A reveals 
that the autoacylation profiles of zDHHC-2, -3, -7 and -15 
were essentially identical to the profiles observed for these 
enzymes with SNAP25 S-acylation (Figure 4). Despite 
repeated attempts, we were unable to reliably detect 
autoacylation of zDHHC17 and therefore could not compare 
the autoacylation profile of this enzyme with its substrate S-
acylation profile. As enzyme autoacylation reliably reports on 
fatty acid selectivity of zDHHC enzymes, we extended this 
analysis to provide a more comprehensive study of the 
zDHHC family. Further distinct fatty acid azide selectivity 
profiles were identified for a set of zDHHC enzymes for which 
autoacylation was readily detectable: zDHHC5 and zDHHC11 
exhibited a preference for C14:0/C16:0 azides, zDHHC4 
showed no preference for C14:0/C16:0/C18:0 azides and 
zDHHC23 displayed a marked preference for C18:0-azide over 
C14:0 and C16:0 azides (Figure 6B). 
Differences in fatty acid selectivities of zDHHC3 and zDHHC7 
are linked to residues in the third transmembrane domain 
To understand how differences in fatty acid selectivity might 
be encoded at the molecular level, we undertook a 
systematic domain swapping analysis of zDHHC3 and 
zDHHC7. These enzymes are highly conserved and thus we 
reasoned that domain swapping between these two isoforms 
should be less likely to produce deleterious effects on protein 
folding than similar analyses of other zDHHC enzymes. 
zDHHC3 and zDHHC7 exhibited a marked difference in ability 
to incorporate the C18:0 azide probe (Figure 7A) and 
therefore we focused on this distinction between these two 
enzymes. This distinction was observed for SNAP25 S-
acylation (Figure 4), enzyme autoacylation (Figure 6), and we 
also confirmed it using a different substrate protein (cysteine-
string protein; SI Appendix, Supplementary Figure 2). zDHHC3 
and zDHHC7 consist of four predicted transmembrane 
domains with cytosolic N- and C-termini and a central 
intracellular loop containing the 51-amino acid catalytic 
DHHC-CRD (See Figure 7B). Interestingly, replacing either the 
N- or C-terminal domain or the DHHC-CRD of zDHHC3 with 
the same domains from zDHHC7 had no detectable effect on 
the fatty acid selectivity profile of zDHHC3 (Figure 7C). In 
contrast, replacing all four transmembrane domains of 
zDHHC3 with those from zDHHC7 or only the second and 
third transmembrane domains resulted in a significant 
increase in C18:0 azide incorporation into SNAP25 by these 
mutant enzymes (Figure 7D), mirroring the fatty acid profile 
of zDHHC7 (see Figure 7A). Further analysis revealed that 
substituting only transmembrane domain three of zDHHC3 
with the same domain from zDHHC7 was sufficient to change 
the C18:0 selectivity profile of zDHHC3 (Figure 7E). 
To pinpoint the specific features of TMD3 that are important 
for dictating the fatty acid selectivity profile of zDHHC3, we 
compared the amino acid sequences of this domain from 
zDHHC3 and zDHHC7 (Figure 8A). There are four differences 
in amino acid sequence between mammalian zDHHC3 and 
zDHHC7 isoforms in this region and thus we generated two 
mutants containing either I182S/L184V or M189L/V190C 
mutations. Figure 8B shows that the I182S/L184V mutation 
led to a marked increase in C18:0 azide incorporation into 
SNAP25 by zDHHC3, whereas the M189L/V190C mutations 
had no effect. Thus, we subsequently generated single I182S 
and L184V mutations, which clearly showed that the I182S 
mutation in zDHHC3 significantly enhanced the level of C18:0 
incorporation by zDHHC3 whereas the L184V mutation had 
no effect (Figure 8C). It is interesting to note that zDHHC7 in 
Danio rerio has an isoleucine rather than a serine residue at 
this position (see Figure 8A). When autoacylation and 
substrate S-acylation profiles of zDHHC3 and zDHHC7 from 
this species were examined, we found no significant 
difference, with both enzymes weakly incorporating the 
C18:0 azide (SI Appendix, Supplementary Figure 3). This 
further supports the key role played by these residues in 
determining fatty acid selectivity profiles of zDHHC enzymes. 
Finally, to exclude the possibility that any findings with the 
fatty acid azide probes were related to the presence of the 
azide/alkyne group, we examined incorporation of [
3
H]-
palmitic acid and [
3
H]-stearic acid into SNAP25 by zDHHC3, 
zDHHC7 and the zDHHC3 (I182S) mutant. Figure 9 shows that 
the level of incorporation of [
3
H]palmitic acid catalysed by 
these zDHHC enzymes was similar. In contrast, zDHHC7 more 
effectively incorporated [
3
H]stearic acid than zDHHC3, and 
the zDHHC3 (I182S) mutant displayed a significant increase in 
[
3
H]stearic acid incorporation compared with wild-type 
zDHHC3 and to a similar level as seen with zDHHC7. Thus, the 
results of these experiments fully support the results 
obtained with the fatty acid azides. 
Discussion 
This study provides the first analysis of zDHHC enzyme fatty 
acid selectivity in cells. The only other study to examine how 
zDHHC enzymes handle acyl CoA substrates explored S-
acylation by purified zDHHC2 and zDHHC3 in detergent 
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micelles(10). Jennings and Linder demonstrated that zDHHC3 
has a strong preference for C16:0 over C18:0 acyl CoA, 
whereas zDHHC2 displays no overt preference(10). 
Importantly, this present study has shown that these 
differences are also seen when zDHHC2 and zDHHC3 are 
expressed in mammalian cells. zDHHC3 is Golgi-localised(26), 
whereas zDHHC2 associates with the plasma membrane and 
endosomes(27). Therefore, the acyl CoA selectivity profiles of 
zDHHC2/3 are preserved irrespective of whether they are in 
detergent micelles or native membranes and irrespective of 
localisation to distinct cellular compartments. 
zDHHC autoacylation provides a robust measure of fatty acid 
selectivity as we clearly showed that the autoacylation profile 
of zDHHC2, -3, -7 and -15 closely match their respective 
substrate S-acylation profiles. This allowed us to investigate 
the acyl CoA selectivity of an additional set of enzymes by 
measuring their autoacylation. The results of this analysis 
showed that zDHHC-3, -5, -7, -11 and -15 prefer C14/C16 over 
C18, zDHHC-2 and -4 display no clear fatty acid preference, 
zDHHC17 prefers C16/C18 over C14, and zDHHC23 exhibits a 
strong preference for C18. These observations re-emphasise 
that acyl CoA specificities do not show any correlation with 
intracellular localisation, for example, zDHHC-3, -7, -15, -17 
and -23 all localise to the Golgi (26, 28), whereas zDHHC-2 
and -5 are localised to the plasma membrane(25), and 
zDHHC4 is ER-localised(29). 
zDHHC-3 and -7 are highly related at the sequence level, 
localise to Golgi membranes and share many common 
protein substrates. Yet these enzymes have a significant 
difference in acyl CoA selectivity, with zDHHC7 having an 
increased ability to incorporate C18:0 chains relative to 
zDHHC3. The high sequence conservation of zDHHC-3 and -7 
provided an opportunity to undertake a comprehensive 
domain swapping analysis to pinpoint features that underpin 
acyl CoA selectivity. This analysis identified a single amino 
acid in the third transmembrane domain of zDHHC3 as a 
critical determinant limiting use of longer chain fatty acids. 
When Ile-182 was replaced by a serine, which is present at 
the same position in zDHHC7, a significant increase in the 
ability of the mutant protein to incorporate C18:0 was noted. 
We confirmed the importance of this residue using both 
C16:0/C18:0 azides with click chemistry detection and 
[
3
H]palmitic acid/stearic acid labelling. It is interesting that 
neither the azide or alkyne group present on the probes 
appeared to influence acyl chain selectivity, perhaps 
suggesting that these chemical groups have a flexible 
character that does not impede association with zDHHC 
enzymes. Consistent with this, we also found that the fatty 
acid azides selectively competed for formation of 
endogenous acyl-CoA of the same chain length when added 
to HEK293T cells. This shows that the azide probes compete 
with and are very good mimics of endogenous fatty acids, 
and are therefore excellent tools with which to interrogate 
aspects of fatty acid biology such as S-acylation.  
Although we performed a comprehensive domain-swapping 
analysis between zDHHC3 and zDHHC7, the high similarity of 
these two enzymes means that other factors that are 
important for acyl chain selectivity could have been missed. 
Nevertheless, the approach taken here provides an important 
first step towards understanding the basis for acyl CoA 
selectivity in the zDHHC family. Interestingly, a lysine was 
identified in the transmembrane domain of an elongase 
component of the yeast very long-chain fatty acid synthase 
complex that was also a key determinant of the final length 
of fatty acid acyl CoA chain synthesised by this enzyme 
complex(30). In addition, a subsequent mutational analysis of 
the related rat elongases Elovl2 and Elovl5 highlighted the 
importance of the transmembrane domains of these enzymes 
in setting the substrate specificity profiles. Elovl2 is required 
for synthesis of omega-3 docosahexaenoic acid (DHA; 22:6n-
3) as this elongase (but not Elovl5) can elongate 
docosapentaenoic acid (22:5n-3) to 24:5n-3, a precursor of 
DHA. This difference in substrate specificity between Elovl2 
and Elovl5 was shown to involve a region encompassing 
transmembrane domains 6 and 7, with a cysteine-to-
tryptophan switch in transmembrane domain 7 proving to be 
particularly important in setting specificity(31). 
It is tempting to speculate that the transmembrane domains 
ŽĨ ǌ,, ĞŶǌǇŵĞƐ ĨŽƌŵ  “ĐŚĂŶŶĞůƐ ? ƚŚĂƚ ĂĐĐŽŵŵŽĚĂƚĞ
specific acyl CoA molecules. This could involve different 
transmembrane domains in the same zDHHC molecule or 
might require dimerization and multimerisation of zDHHC 
enzymes(32). As isoleucine occupies more space that serine, 
it is possible that this amino acid in TMD3 of zDHHC3 limits 
the length of acyl chain that can be accommodated by 
blocking the acyl-CoA channel. This idea is consistent with the 
position of the isoleucine residue in zDHHC3, which is present 
in the middle of TMD3. Indeed, the catalytic DHHC-CRD of 
zDHHC enzymes is present immediately preceding TMD3, 
suggesting that the cysteine in the DHHC active site could be 
positioned close to the channel opening. 
Mass spectrometry analysis of haemaglutinin (HA) from 
influenza has shown that C18:0 is added specifically to a 
cysteine present in the transmembrane domain, whereas 
C16:0 is attached to cysteines in a membrane proximal region 
(33). It is not clear how this highly selective process is 
achieved but our results suggest that the modified cysteines 
in HA might be targets of different zDHHC enzymes with 
distinct acyl CoA specificities. It is also possible that there is 
sometimes a contribution made by the substrate in 
determining which fatty acids are attached. Thus, for 
transmembrane proteins, the sequence of the 
transmembrane domain could affect which fatty acids are 
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added to membrane-proximal cysteines in a similar way as 
seen here for zDHHC enzymes. 
There are two major properties of S-acylation that are 
thought to be central to its various effects on modified 
proteins: hydrophobicity and affinity for cholesterol-rich 
membranes(3, 34). Hydrophobicity is fundamental to the 
effects of S-acylation on reversible membrane binding of 
many soluble proteins and in regulating the membrane 
association of soluble loops of transmembrane proteins(3). 
Association with cholesterol-rich membranes is thought to 
influence aspects of protein trafficking and membrane 
compartmentalisation. It is well established from in vitro 
studies that saturated phospholipids cluster together with 
cholesterol, whereas unsaturated phospholipids are excluded 
from these domains(35). Although the effects of saturated 
versus unsaturated S-acyl chains have not been studied in 
such detail, it is clear that S-acylation is a major signal for 
association with cholesterol-rich domains at least in vitro(36). 
It is likely that the addition of saturated versus unsaturated 
acyl chains onto proteins have distinct influences on 
membrane partitioning and subsequent trafficking and 
function in the cell. Furthermore, the acyl chain added to S-
acylated proteins is also likely to affect the strength of 
membrane association. Although two tandem lipid 
modifications (e.g. myristoylation/palmitoylation or 
prenylation/palmitoylation) provide a strong membrane 
anchor, a single lipid group (e.g. myristoyl or prenyl) is not 
sufficient for membrane association (37). However, single 
myristate, palmitate or stearate groups added to an S-
acylated protein could have different effects on membrane 
association. Indeed, stearate has a significantly stronger 
interaction with phospholipid membranes than 
palmitate(12). 
This study identified clear differences in the acylation profiles 
of different zDHHC enzymes and their substrates expressed in 
HEK293T cells. In future work it will be important to further 
advance understanding of this area and the functional 
significance of fatty acid heterogeneity by investigating fatty 
acid selectivity of endogenous proteins and how this is 
impacted by a dynamic and heterogeneous acyl CoA pool. 
The distribution of different pools of acyl-CoAs and their 
availability for use in S-acylation reactions is unclear, and this 
is also an important area for future investigations. 
Materials and Methods 
Materials 
Mouse GFP antibody was from Clontech (CA, USA). Rat HA 
antibody was from Roche (West Sussex, UK). Danio rerio 
zDHHC3 and zDHHC7 coding sequences were synthesised by 
GeneArt (Thermo Fisher). IR-dye conjugated secondary 
antibodies and alkyne/azide probes were purchased from LI-
COR (Cambridge UK). [9,10-
3
H] palmitic acid and [9,10-
3
H] 
stearic acid (specific activity for each 1.11-2.22 TBq/mmol) 
were from Hartmann Analytic (Braunschweig, Germany). 
Cell transfection 
For substrate S-acylation assays, HEK293T cells plated on 24-
well plates were transfected using Lipofectamine 2000 
(Invitrogen) with 0.8 Pg of EGFP-SNAP25 and 1.6 Pg of zDHHC 
plasmid (in pEF-BOS-HA backbone). For autoacylation assays, 
3 Pg of zDHHC plasmid was used. Cells were labelled and 
processed the day after transfection. 
Quantification of fatty acids and acyl-CoAs 
Cells were collected by centrifugation and washed with 
serum-free DMEM, prior to incubation at 37 °C for 15 min 
with DMEM only, followed by the addition of defatted BSA 
coupled to the appropriate fatty acid azide (100 µM final 
concentration) and incubated for 4 hours at 37ºC. Cells were 
then harvested by centrifugation and either washed in ice-
cold PBS and freeze-dried for total fatty acid determination or 
processed for acyl-CoA extraction (see below).  
For total fatty acid determination, the freeze-dried cells were 
subjected to acid hydrolysis using constant boiling HCl (6 M, 
 ? ? ?ʅ> ?ǀŽƌƚĞǆŝŶŐ ?ƐŽŶŝĐĂƚŝŽŶĨŽůůŽǁĞĚby incubation for 16 h 
at 110 °C. After cooling, the samples were spiked with 100 
pmoles of C17:0 fatty acid (as an internal control) and 
processed and derivatised to fatty acid methyl esters 
(FAMEs), prior to analysis by gas chromatography-mass 
spectrometry (GC-MS) as described previously(38). The 
individual azide fatty acids were also converted to their 
corresponding FAMEs and analysed by GC-MS to determine 
retention time and fragmentation patterns. 
For acyl-CoA extraction and quantification, the absolute 
number of cells was determined (typically between 2-4 x 10
7
 
cells). Cells were harvested by centrifugation at 15,000 x g for 
1 min at room temperature and the supernatant media 
removed. The pellet was washed with 200 Pl of ice-cold PBS 
and completely lysed with ice-cold TCA (100 Pl, 1 M) and 
vortexing, and stored on ice to prevent sample hydrolysis. 
The internal standard C17:0-CoA (150 pmol) was added to the 
lysate and the sample centrifuged (15,000g, 10 min, 4qC).  
The resulting supernatant was transferred to a fresh pre-
cooled tube. EDTA (25 Pl, 10 mM, pH 7.0) was added 
followed by chloroform (50 PL) triethylammonium acetate 
(50 Pl), and the mixture was vortexed and centrifuged 
(15,000 x g, 10 min, 4qC). The upper phase was carefully 
removed to a fresh Eppendorf tube, flash frozen in liquid 
nitrogen and freeze-dried. The dried sample was kept at -
80qC prior to analysis by electrospray-mass spectrometry (ES-
MS), using multiple reaction monitoring (MRM) similar to the 
method of Haynes et al(17). 
^ĂŵƉůĞƐǁĞƌĞƐƵƐƉĞŶĚĞĚŝŶ  ? ?ʅl of a 1:2 (v/v) chloroform / 
ŵĞƚŚĂŶŽůĂŶĚ ?ʅl of acetonitrile / isopropanol / water (6:7:2) 
and delivered using a NanoMate (Advion) to a AB Sciex 4000 
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QTRAP triple quadrupole mass-spectrometry with a 
nanoelectrospray source, using nitrogen as the collision gas. 
A MRM approach was utilized to quantify acyl CoA. MRM 
mass transition (SI Appendix, Table 1) for the acyl-CoAs was 
determined in positive ion mode, (EP 8 eV, CXP 12 eV, an 
interface temperature of 30 °C , gas pressure 0.5 psi and a tip 
voltage of 1.25-1.5kV, dwell time 500 mS), spectra were 
acquired for 2 minutes. All MRM data were normalized 
relative to the internal standard before generating standard 
curves (0.1-500 pmoles) for the acyl-CoAs (C14:0. C16:0, 
C17:0, C18:0, C20 and C20:4) which were obtained from 
either Sigma or Avanti Polar Lipids (Alabaster, AL), allowing 
their own response factor to be determined. Samples were 
analysed in the same manner, allowing quantification of the 
extracted acyl-CoAs. 
Cell labelling with fatty acid azide and alkyne probes for 
analysis of S-acylation 
HEK293T cells were incubated with 100 PM of the fatty acid 
azide probes (in DMEM with 1 mg/ml defatted BSA) for 4 h at 
37 
°
C. For competition experiments, transfected cells were 
labelled with 100 µM of the C16:0 azide probe in the 
presence of a 3-fold excess (300 µM) of the relevant fatty 
acid. For cell labelling with [
3
H]palmitic acid and [
3
H]stearic 
acid (Hartmann Analytic), transfected cells were incubated in 
DMEM/BSA containing 0.5 mCi/ml of the tritiated fatty acid 
probes for 4 h at 37 
°
C. 
Detection of fatty acid azide and alkyne probes in S-acylated 
proteins 
Cells were washed twice in PBS then lysed on ice in 100 Pl of 
50mM Tris pH 8.0 containing 0.5% SDS and protease 
inhibitors (Roche, West Sussex UK). Conjugation of azide or 
alkyne IR-800 Dye (LI-COR, Cambridge UK) to fatty acid azide 
or alkyne probes was carried out for 1 h at room temperature 
with end-over-end rotation by adding an equal volume (100 
Pl) of freshly mixed click chemistry reaction mixture 
containing 10 PM IRDye® 800CW azide or alkyne Infrared 
Dye, 4 mM CuSO4, 400PM Tris[(1-benzyl-1H-1,2,3-triazol-4-
yl)methyl]amine and 8 mM ascorbic Acid in dH20. Proteins 
were isolated by acetone precipitation and resuspended in 
100 Pl SDS sample buffer containing 25 mM DTT. Samples 
were incubated at 95 °C for 5 min and 10-15 Pl was resolved 
by SDS-PAGE.  
For detection of [
3
H] fatty acid probes, cell lysates were 
resolved by SDS-PAGE and transferred to duplicate 
nitrocellulose membranes. One membrane was used for 
immunoblotting, the other was exposed to light-sensitive film 
in the presence of a Kodak Biomax Transcreen LE intensifier 
screen for detection of [
3
H]. 
Generation of mutant zDHHC constructs 
The zDHHC3 chimeras containing the N- and C-terminal 
domains (zDHHC3/CN7) or intracellular domain including the 
zDHHC cysteine-rich domain of zDHHC7 (zDHHC3/CRD7) were 
generated within the HA-tagged constructs by inserting Nhe1 
and Sal1 restriction sites at the boundaries of the domains 
that were swapped (upstream of C47 and F235 in zDHHC3 
and C50 and F238 in zDHHC7 for zDHHC3/CN7, and S93 and 
T176 in zDHHC3 and S96 and T179 in zDHHC7 for 
zDHHC3/CRD7) by site-directed mutagenesis. The regions 
were then swapped by restriction/ligation and the Nhe1/Sal1 
restriction sites removed using site-directed mutagenesis. 
The zDHHC3 chimeras containing the transmembrane 
domains of zDHHC7 were constructed by GeneArt and sub-
cloned into pEF-BOS-HA vector using BamH1 restrictions 
sites. The transmembrane domains predicted by UniProt 
were defined as follows: zDHHC3 A48-V68 (TMD1), Y73-S93 
(TMD2), F172-F192 (TMD3), I215-F235 (TMD4); zDHHC7 A51-
L71 (TMD1), F76-S96 (TMD2), F175-G194 (TMD3), I218-F238 
(TMD4). Site-directed mutants were generated using PCR. 
The validity of all clones was confirmed by sequencing. 
Data Quantification and Statistical Analysis 
Quantification of all click chemistry experiments was 
performed by expressing the click signal relative to the 
corresponding protein signal (immunoblot). For substrate S-
acylation assays, this was then normalised to empty vector 
control. Statistical analysis used a one-way ANOVA with a 
Tukey post-test (Graphpad Prism software). 
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Figure Legends 
 
Figure 1: Relative percentage of the total fatty acid content of cells with and without treatments of azide-fatty acids. 
HEK293T cells were incubated with or without fatty acid azides. Fatty acids released from cellular lipids and protein by acid were 
then converted to methyl esters and analysed by GC-MS as described in material and methods. Values shown are means ± SEM 
(n=3). 
 
Figure 2: Quantification of the acyl-CoA content of HEK293T cells with and without treatments of azide-fatty acids. 
HEK293T cells were incubated with or without fatty acid azides and acyl-CoAs were then quantified as described in materials and 
methods. Values shown are means ± SEM (n=3). 
 
Figure 3: S-acylation of EGFP-SNAP25B by zDHHC3. 
HEK293T cells were transfected with EGFP-SNAP25B and pEF-BOS-HA (vector), HA-zDHHC3, or HA-zDHHC(C157S), or were left 
untransfected. Cells were then incubated with C14:0, C16:0 or C18:0 fatty acid azides for 4 h at 37 °C. Incorporated fatty acid azides 
were detected by click chemistry using an alkyne-800 infrared dye. Isolated proteins were resolved by SDS-PAGE and transferred to 
nitrocellulose membranes. Representative images are shown. (a) Upper panel: click chemistry signal. Middle panel: anti-GFP 
immunoblot. Lower panel: anti-HA immunoblot. Arrowheads denote the position of the EGFP-SNAP25 band (top and middle panels) 
and hA-zDHHC3 band (lower panel). (b) Following click chemistry, samples were incubated in hydroxylamine (+) or Tris (-) at a final 
concentration of 1 M overnight prior to SDS-PAGE. Upper panel: click chemistry signal. Lower panel: anti-GFP immunoblot. Position 
of molecular weight markers is shown. 
 
Figure 4: S-acylation of EGFP-SNAP25B by different zDHHC enzymes. 
HEK293T cells were transfected with EGFP-SNAP25B and pEF-BOS-HA (vector), HA-zDHHC-2, -3, -7, -15 or -17. Cells were then 
incubated with C14:0, C16:0 or C18:0 fatty acid azides or alkynes as indicated for 4 h at 37 °C. Fatty acid azides/alkynes were 
labelled by click chemistry using an alkyne- or azide-800 infrared dye. Isolated proteins were then resolved by SDS-PAGE and 
transferred to nitrocellulose membranes. (a) S-acylation analysis of EGFP-SNAP25B using fatty acid-azides. Representative images 
are shown in the left panel with position of molecular mass standards indicated; graphs showing mean ± SEM shown are in the right 
panel. zDHHC3: n = 46; zDHHC7: n = 26; zDHHC2: n= 10; zDHHC15: n = 9; zDHHC17: n = 22. **p < 0.01; ***p < 0.001. (b) S-acylation 
analysis of EGFP-SNAP25B in HEK293T cells labelled with fatty acid-alkynes. Graphs show mean ± SEM (n=10). ns = not significant; 
**p < 0.01; ***p < 0.001. 
 
Figure 5: S-acylation of EGFP-SNAP25B by longer-chain saturated and unsaturated fatty acids.  
(a) S-acylation analysis of EGFP-SNAP25B by HA-zDHHC3, HA-zDHHC7 and HA-zDHHC17 in HEK293T cells with C14:0, C16:0, C18:0, 
C20:0 and C22:0 fatty acid-azides. Representative images are shown and position of molecular mass standards indicated. Upper 
panel: click chemistry signal. Middle panel: anti-'&WŝŵŵƵŶŽďůŽƚ ?>ŽǁĞƌƉĂŶĞů PƋƵĂŶƚŝĨŝĞĚĚĂƚĂ ?Ŷш ? ?ŵĞĂŶц^D ? ?ď ?ŽŵƉĞƚŝƚŝŽŶ
analysis of EGFP-SNAP25B S-acylation by HA-zDHHC3 (upper panel) or HA-zDHHC17 (lower panel) in HEK293T cells labelled with 
C16:0-azide in the presence of 3-fold excess of the indicated unlabelled (u) fatty acids. Position of molecular mass standards is 
shown. 'ƌĂƉŚƐƐŚŽǁŵĞĂŶǀĂůƵĞƐц^D ?Ŷш ? ? ?ŶƐсŶŽƚƐŝŐŶŝĨŝĐĂŶƚ ? 踁?ф ? ? ? ? ? ? ?Ɖф ? ? ? ? ? ? ? ?Ɖф ? ? ? ? ? ? 
 
Figure 6: Autoacylation of zDHHC enzymes by fatty-acid azides.  
HEK293T cells transfected with HA-tagged zDHHC constructs were incubated with C14:0, C16:0 or C18:0 fatty acid azides for 4h at 37 
°C. Fatty acid azides were then labelled by click chemistry using an alkyne-800 infrared dye. Isolated proteins were resolved by SDS-
PAGE and transferred to nitrocellulose membranes.  Representative click signals and western blots with position of molecular mass 
standards indicated, together with quantified data (mean ± SEM) are shown for each zDHHC enzyme. (a) Autoacylation of zDHHC 
enzymes active against SNAP25B. zDHHC2: n = 6; zDHHC3: n = 14; zDHHC7: n = 11; zDHHC15: n = 6. (b) Autoacylation of additional 
ǌ,,ĞŶǌǇŵĞƐ ?Ŷш ? ?ŶƐсŶŽƚƐŝŐŶŝĨŝĐĂŶƚ ? ?Ɖф ? ? ? ? ? ? ?Ɖф ?  ? ? ? ? ? ?Ɖф ? ? ? ? ? ?The arrowhead on the zDHHC5 blot indicates the 
zDHHC5 band. 
 
Figure 7: S-acylation of EGFP-SNAP25B by zDHHC3/zDHHC7 chimeras. 
HEK293T cells were transfected with EGFP-SNAP25B and pEF-BOS-HA (vector) or the indicated wild-type or mutant zDHHC 
constructs. Cells were then incubated with C14:0, C16:0 or C18:0 fatty acid azides for 4h at 37 ºC. Fatty acid azides were labelled by 
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click chemistry using an alkyne-800 infrared dye. Isolated proteins were then resolved by SDS-PAGE and transferred to nitrocellulose 
membranes for analysis. (a) Quantification of the relative levels of C14:0-, C16:0- or C18:0-azide incorporation into EGFP-SNAP25B 
ďǇ ǌ,, ? Žƌ ǌ,, ?  ?ŵĞĂŶ ц ^D ? ? Ŷ ш  ? ? ?  ?ď ? ^ĐŚĞŵĂƚŝĐŝůůƵƐƚƌĂƚŝŽŶ detailing the zDHHC3/zDHHC7 chimeras that were 
constructed. (c-e) Analysis of EGFP-SNAP25B S-acylation by zDHHC3 chimeras with fatty acid-azides. Representative images are 
shown on the left, graphs showing mean ± SEM are on ƚŚĞƌŝŐŚƚ ? ?Đ ?Ŷш ? ? ?Ě ?Ŷс ? ? ?Ğ ?Ŷш ? ? ?ŶƐсŶŽƚƐŝŐŶŝĨŝĐĂŶƚ ? 踃? ?Ɖф ? ? ? ? ? ? 
 
Figure 8: S-acylation of EGFP-SNAP25B by zDHHC3 TMD3 mutants. 
HEK293T cells were transfected with EGFP-SNAP25B and pEF-BOS-HA (vector) or the indicated wild-type or mutant zDHHC 
constructs. Cells were then incubated with C14:0, C16:0 or C18:0 fatty acid azides for 4 h at 37 °C. Fatty acid azides were labelled by 
click chemistry using an alkyne-800 infrared dye. Isolated proteins were resolved by SDS-PAGE and transferred to nitrocellulose 
membranes. (a) Sequence alignment of amino acids in the third transmembrane domain of zDHHC3 and zDHHC7; the blue boxes 
highlight Isoleucine-182 in zDHHC3 and Serine-185 in zDHHC7. (b) and (c) Analysis of EGFP-SNAP25B S-acylation by zDHHC3 TMD3 
mutants with fatty acid-azides. Representative images are shown on the left, graphs showing mean ± SEM are on the ƌŝŐŚƚ ? ?ď ?Ŷш ? ?
 ?Đ ?Ŷш ? ?ŶƐсŶŽƚƐŝŐŶŝĨŝĐĂŶƚ ? ? ? ?Ɖф ? ? ? ? ? ? 
 
Figure 9: Incorporation of [
3
H]palmitic and [
3
H]stearic acid into EGFP-SNAP25B by zDHHC3 and zDHHC7. 
HEK293T cells were transfected with pEGFPC2 or EGFP-SNAP25B together with pEF-BOS-HA (vector), HA-zDHHC3, HA-zDHHC7, or 
HA-zDHHC3(I182S). Cells were labelled with either [
3
H]palmitic acid (Left panel) or [
3
H]stearic acid (Right panel), lysed, and resolved 
by SDS-PAGE. Top panel: [
3
H] fatty acid incorporation. Upper middle panel: expression levels of EGFP-SNAP25B. Lower middle panel: 
zDHHC protein expression. Molecular weight markers are shown on the left. Lower panel: Quantification of [
3
H] fatty acid 
incorporation normalised to EGFP-SNAP25B protein levels expressed as mean ± SEM. n = 3, ns = not significant. **p < 0.01; ***p < 
0.001. 
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Molecular basis of fatty acid selectivity in the zDHHC family of S-acyltransferases 
revealed by click chemistry 
Greaves et al 
SUPPLEMENTARY INFORMATION APPENDIX 
General Experimental Details 
Unless otherwise stated, all commercially available reagents were used as supplied without any 
further purification. nBuLi was purchased as a 2.5 M solution, and the solution was titrated with 
diphenylacetic acid prior to use. Dry THF was used directly from a PureSolv MD 5 Solvent 
Purification System by Innovative Technology Inc., and handled under inert atmosphere. 1,3-
Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone) (DMPU) was dried by heating to reflux over 
calcium hydride and distilling under vacuum before being purged with, and stored under N2 over 4 Å 
molecular sieves. Flash chromatography was carried out using Merck Kieselgel 60 H silica. 
Analytical thin layer chromatography was carried out using aluminium-backed plates coated with 
Merck Kieselgel 60 GF254 that were visualised using p-anisaldehyde. Nuclear magnetic resonance 
(NMR) spectra were recorded on a 400 MHz Ultrashield Magnet, Prodigy liquid nitrogen 
cryoprobe, AVIII console and a Z420 HP workstation running TopSpin 3.X running at 400 MHz (1H 
NMR) and 101 MHz (13& 105 DQ  0+] $VFHQG PDJQHW %%2 PXOWL QXF¶ 6PDUW SUREH
AVIIIHD500 console and Z420 HP workstation running TopSpin 3.X running at 500 MHz (1H NMR) 
and 126 MHz (13&105RUD0+]8OWUDVKLHOGPDJQHW%%2PXOWLQXF¶SUREHAVII+ console 
and a  Z420 HP workstation running TopSpin 3.X running at 600 MHz (1H NMR) or 151 MHz (13C 
NMR). Chemical shifts are reported in parts per million (ppm) in the scale relative to CDCl3, 
7.26 ppm for 1H NMR and 77.16 for 13C NMR; DMSO-d6, 2.50 ppm for 1H NMR and 39.52 
for 13C NMR. Coupling constants are measured in Hertz (Hz). Low-resolution mass spectra 
(LRMS) were recorded on an Agilent 6130 single quadrupole with APCI/ESI dual source, on 
a ThermoQuest Finnigan LCQ DUO electrospray, or on an Agilent 7890A GC system, 
equipped with a 30 m DB5MS column connected to a 5975C inert XL CI MSD with Triple-
Axis Detector. MALDI were performed on an Axima-CFR from Kratos-Shimadzu. 
High-resolution mass spectra (HRMS) were obtained courtesy of the EPSRC National Mass 
Spectrometry Facility at Swansea University, UK. Infrared spectra were recorded on an 
Agilent 5500a FTIR equipped with ATR (Attenuated Total Reflectance) and were reported in 
cm±1. In vacuo refers to evaporation under reduced pressure using a rotary evaporator 
connected to a diaphragm pump, followed by the removal of trace volatiles using a high 
vacuum (oil) pump. Melting points were determined with a Gallenkamp SG92 melting point 
apparatus and are uncorrected. 
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Preparation of fatty acid azide and alkyne chemical probes 
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Preparation of 1,14-tetradecanediol 7(1) 
 
 Reaction performed under a N2 atmosphere. 
 Solid LiAlH4 (1.47 g, 38.7 mmol) was added to a solution of 1,14-tetradecanedioic acid 
(5.00 g, 19.35 mmol) in THF (194 mL) at 0 °C. The reaction was allowed to warm to room 
temperature and stirred at room temperature for 20 h. Upon completion, wet NaSO4 was added 
portion-wise until the grey suspension turned white. The suspension was stirred at room temperature 
until the white solid was free-flowing, and solid MgSO4 was added. The reaction was filtered and the 
filter cake washed with Et2O (5 × 50 mL). The solvent was evaporated in vacuo to afford the product 
(3.88 g, 87%) as a white solid. 
įH (600 MHz, DMSO-d6) 4.29 (t, 2H, J 5.0 Hz, 2 × OH), 3.35±3.38 (m, 4H, 2 × CH2OH), 1.36±1.42 
(m, 4H, 2 × CH2CH2OH), 1.22±1.29 (m, 20H, 10 × CH2). 
įC (151 MHz, DMSO-d6) 60.7, 32.5, 29.1, 29.0, 29.0, 28.9, 25.5. 
LR-MS (MALDI-TOF) 253.2 ([M+Na]+) 
HR-MS calcd for C14H31O2+ ([M+H]+) 231.2318, found 231.2318. 
ȣmax (thin film, cm-1) 3410, 3351, 2921, 2891, 2850. 
Mp 88±90 °C (lit. 87±89 °C)(1) 
 
Preparation of 14-bromotetradecan-1-ol 12(2, 3) 
 
 HBr (48% in H2O, 41 mL) was added to a suspension of diol 7 (3.57 g, 15.5 mmol) in 
cyclohexane (41 mL). The biphasic mixture was heated to reflux for 10 h before being cooled to room 
temperature. The layers were separated and the aqueous phase extracted with CH2Cl2 (4 × 30 mL). 
The combined organics were washed with NaHCO3 (4 × 20 mL of a saturated aqueous solution), brine 
(20 mL), dried over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by 
column chromatography, eluting with 95:5 petrol/EtOAc then 70:30 petrol/EtOAc, to afford the 
product (2.85 g, 63%) as a pale yellow solid. 
įH (400 MHz, CDCl3) 3.64 (t, 2H, J 6.6 Hz, CH2OH), 3.40 (t, 2H, J 6.9 Hz, CH2Br), 1.80±1.90 (m, 
2H, CH2CH2Br), 1.53±1.60 (m, 2H, CH2CH2OH), 1.25±1.46 (m, 20H, 10 × CH2). 
įC (101 MHz, CDCl3) 63.2, 34.2, 33.0, 33.0, 29.7, 29.7, 29.6, 28.3, 28.9. 
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LR-MS (EI+) 294.9 ([M(81Br)+H]+), 292.9 ([M(79Br)+H]+), 276.9 ([M(81Br)-H2O+H]+), 
292.9 ([M(79Br)-H2O+H]+), 213.9 ([M-Br+H]+). 
HR-MS calcd for C14H33ON79Br+ ([M+NH4]+) 310.1740, found 310.1744. 
ȣmax (thin film, cm-1) 3274, 2919, 2850. 
Mp 46±48 °C (lit. 42±43 °C)(3) 
Preparation of 14-bromotetradecanoic acid 17(4, 5) 
 
 CrO3 (3.89 g, 38.92 mmol) was dissolved in concentrated H2SO4 (7.2 mL). Cold H2O 
(16.2 mL) was added slowly and the solution stirred at room temperature for 10 min. The resulting 
solution was added drop-wise to a solution of alcohol 12 (2.85 g, 9.73 mmol) in acetone (243 mL). 
The reaction was stirred at room temperature for 20 h before being H2O (100 mL) and CH2Cl2 
(40 mL) were added. The layers were separated and the aqueous phase extracted with CH2Cl2 
(4 × 30 mL). The combined organics were washed with brine (30 mL), dried over MgSO4, filtered and 
concentrated in vacuo. The crude residue was purified by column chromatography, eluting with 90:10 
petrol/EtOAc (+0.1% AcOH), to afford the product (2.63 g, 88%) as a white solid. 
įH (400 MHz, CDCl3) 3.41 (t, 2H, J 6.9 Hz, CH2Br), 2.35 (t, 2H, J 7.5 Hz, CH2CO2H), 1.81±1.89 (m, 
2H, CH2CH2Br), 1.59±1.68 (m, 2H, CH2CH2CO2H), 1.24±1.45 (m, 18H, 9 × CH2). 
įC (101 MHz, CDCl3) 179.0, 34.2, 34.0, 33.0, 29.7, 29.7, 29.6, 29.4, 29.2, 28.9, 28.3, 24.8. 
LR-MS (EI+) 309.0 ([M(81Br)+H]+), 307.0 ([M(79Br)+H]+), 291.0 ([M(81Br)-H2O+H]+), 
289.0 ([M(79Br)-H2O+H]+), 227.1 ([M-Br+H]+). 
HR-MS calcd for C14H26O79BrǦ ([M-H]Ǧ) 305.1122, found 305.1123. 
ȣmax (thin film, cm-1) 3036, 2917, 2852, 1696 
Mp 63±66 °C (lit. 64±65 °C)(5) 
Preparation of 14-azidotetradecanoic acid 22(4, 6) 
 
 Reaction performed under a N2 atmosphere 
 NaN3 (636 mg, 9.78 mmol) was added to a solution of bromide 17 (500 mg, 1.63 mmol) in 
DMF (6.5 mL). The reaction was stirred at 80 °C for 40 h before being cooled to room temperature. A 
1:1 mixture  of EtOAc/H2O (20 mL) was added, the layers separated and the aqueous phase 
extracted with EtOAc (3 × 10 mL). The combined organics were washed with brine (10 mL), dried 
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over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by column 
chromatography, eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (403 mg, 
92%) as a white solid. 
įH (400 MHz, CDCl3) 3.25 (t, 2H, J 7.0 Hz, CH2N3), 2.34 (t, 2H, J 7.5 Hz, CH2CO2H), 1.55±1.68 (m, 
4H, CH2CH2N3, CH2CH2CO2H), 1.23±1.38 (m, 18H, 9 × CH2). 
įC (101 MHz, CDCl3) 180.1, 51.6, 34.2, 29.7, 29.6, 29.6, 29.5, 29.4, 29.3, 29.2, 29.0, 26.9, 24.8. 
LR-MS (ES-) 268.1 ([M-H]Ǧ), 240.1 ([M-N2-H]Ǧ). 
HR-MS calcd for C14H26N3O2Ǧ ([M-H]Ǧ) 268.2031, found 268.2028. 
ȣmax (thin film, cm-1) 3016, 2915, 2848, 2101, 1701. 
Mp 38±40 °C. 
 
Preparation of 16-(trimethylsilyl)hexadec-15-ynoic acid 27 
 
 Reaction performed under a N2 atmosphere. 
 
nBuLi (2.19 M, 7.46 mL, 16.3 mmol) was added drop-wise to a solution of 
(trimethylsilyl)acetylene (1.6 g, 2.3 mL, 16.3 mmol) in THF (10 mL) at -78 °C. The reaction was 
stirred at -78 °C for 1 h before DMPU (18 mL) was added and the reaction stirred for a further 
30 min. A solution of bromide 17 (500 mg, 1.63 mmol) in THF (37 mL) was added drop-wise and the 
reaction stirred at room temperature for 48 h. Upon completion, the reaction was quenched with HCl 
(20 mL of a 1 M solution). The layers were separated and the aqueous phase extracted with Et2O 
(4 × 20 mL). The combined organics were washed with brine (3 × 20 mL), dried over MgSO4, filtered 
and concentrated in vacuo. The crude residue was purified by column chromatography, eluting with 
90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (407 mg, 77%) as a white solid. 
įH (400 MHz, CDCl3) 2.34 (t, 2H, J 7.5 Hz, CH2CO2H), 2.20 (t, 2H, J 7.2 Hz, CH2&Ł&6L±1.67 
(m, 2H, CH2CH2CO2H), 1.46±1.55 (m, 2H, CH2CH2CŁ&6L±1.39 (m, 18H, 9 × CH2), 0.14 (s, 
9H, Si(CH3)3). 
įC (101 MHz, CDCl3) 180.3, 107.9, 84.4, 34.2, 29.7, 29.6, 29.6, 29.4, 29.2, 28.9, 28.8, 24.8, 20.0, 0.3. 
LR-MS (ES-) 323.2 ([M-H]Ǧ). 
HR-MS calcd for C19H35O2SiǦ ([M-H]Ǧ) 323.2412, found 323.2408. 
ȣmax (thin film, cm-1) 2939, 2921, 2852, 2178, 1714, 1699. 
Mp 37±40 °C 
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Preparation of hexadec-15-ynoic acid 30(7, 8) 
 
 K2CO3 (285 mg, 2.06 mmol) was added to a solution of TMS-alkyne 27 (268 mg, 0.82 mmol) 
in methanol (8.2 mL) at room temperature. The reaction was stirred at room temperature for 20 h 
before the solvent was evaporated in vacuo. The residue was dissolved in EtOAc (15 mL) and HCl 
(15 mL of a 1 M aqueous solution) added. The layers were separated and the aqueous phase extracted 
with EtOAc (3 × 20 mL). The combined organics were washed with brine (20 mL), dried over 
MgSO4, filtered and concentrated in vacuo. The crude residue was purified by column 
chromatography, eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (200 mg, 
97%) as a white solid. 
įH (400 MHz, CDCl3) 2.34 (t, 2H, J 7.5 Hz, CH2CO2H), 2.18 (td, 2H, J 7.1 Hz, 4J 2.7 Hz, CH2&Ł&+
1.93 (t, 1H, 4J +]&Ł&H), 1.58±1.67 (m, 2H, CH2CH2CO2H), 1.47±1.55 (m, 2H, CH2CH2CŁ&+
1.25±1.43 (m, 18H, 9 × CH2). 
įC (101 MHz, CDCl3) 180.3, 85.0, 68.2, 34.2, 29.7, 29.6, 29.6, 29.4, 29.2, 29.2, 28.9, 28.6, 24.8, 18.5. 
LR-MS (ES-) 251.2 ([M-H]Ǧ). 
HR-MS calcd for C16H27O2Ǧ ([M-H]Ǧ) 251.2017, found 251.2017. 
ȣmax (thin film, cm-1) 3285, 3042, 2917, 2852, 2115, 1694. 
Mp 59±61 °C. 
Preparation of 1,16-hexadecanediol 8(9) 
 
 Reaction performed under a N2 atmosphere. 
 Solid LiAlH4 (1.33 g, 34.9 mmol) was added to a solution of 1,16-hexadecanedioic acid 
(5.00 g, 17.46 mmol) in THF (175 mL) at 0 °C. The reaction was allowed to warm to room 
temperature and stirred at room temperature for 20 h. Upon completion, wet NaSO4 was added 
portion-wise until the grey suspension turned white. The suspension was stirred at room temperature 
until the white solid was free-flowing, and solid MgSO4 was added. The reaction was filtered and the 
filter cake washed with Et2O (5 × 50 mL). The solvent was evaporated in vacuo to afford the product 
(3.68 g, 82%) as a white solid. 
įH (600 MHz, DMSO-d6) 4.29 (t, 2H, J 4.9 Hz, 2 × OH), 3.34±3.39 (m, 4H, 2 × CH2OH), 1.36±1.42 
(m, 4H, 2 × CH2CH2OH), 1.22±1.29 (m, 24H, 12 × CH2). 
įC (151 MHz, DMSO-d6) 60.7, 32.5, 29.1, 29.0, 29.0, 29.0, 28.9, 25.5. 
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LR-MS (MALDI-TOF) 281.3 ([M+Na]+), 297.3 ([M+K]+). 
HR-MS calcd for C16H35O2+ ([M+H]+) 259.2632, found 259.2632. 
ȣmax (thin film, cm-1) 3414, 3353, 2919, 2891, 2848. 
Mp 91-94 °C (lit. 93±94 °C)(9) 
 
Preparation of 16-bromohexadecan-1-ol 13(10, 11) 
 
 HBr (48% in H2O, 36 mL) was added to a suspension of diol 8 (3.48 g, 13.5 mmol) in 
cyclohexane (36 mL). The biphasic mixture was heated to reflux for 10 h before being cooled to room 
temperature. The layers were separated and the aqueous phase extracted with CH2Cl2 (4 × 30 mL). 
The combined organics were washed with NaHCO3 (4 × 20 mL of a saturated aqueous solution), brine 
(20 mL), dried over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by 
column chromatography, eluting with 95:5 petrol/EtOAc then 70:30 petrol/EtOAc, to afford the 
product (2.40 g, 55%) as a pale yellow solid. 
įH (400 MHz, CDCl3) 3.64 (t, 2H, J 6.6 Hz, CH2OH), 3.41 (t, 2H, J 6.9 Hz, CH2Br), 1.80±1.91 (m, 
2H, CH2CH2Br), 1.52±1.62 (m, 2H, CH2CH2OH), 1.25±1.46 (m, 24H, 12 × CH2). 
įC (101 MHz, CDCl3) 63.3, 34.2, 33.0, 33.0, 29.8, 29.8, 29.7, 29.6, 28.9, 28.3, 25.9. 
LR-MS (EI+) 320.9 ([M(81Br)+H]+), 318.9 ([M(79Br)+H]+), 304.9 ([M(81Br)-H2O+H]+), 302.9 
([M(79Br)-H2O+H]+), 241.8 ([M-Br+H]+). 
HR-MS calcd for C16H3779BrON+ ([M+NH4]+) 338.2053, found 338.2056. 
ȣmax (thin film, cm-1) 3274, 2917, 2850. 
Mp 54-56 °C (lit. 54±56 °C)(12) 
Preparation of 16-bromohexadecanoic acid 18(13) 
 
 CrO3 (3.00 g, 30.0 mmol) was dissolved in concentrated H2SO4 (5.5 mL). Cold 
H2O (12.5 mL) was added slowly and the solution stirred at room temperature for 10 min. The 
resulting solution was added drop-wise to a solution of alcohol 13 (2.40 g, 7.50 mmol) in acetone 
(188 mL). The reaction was stirred at room temperature for 20 h before being H2O (100 mL) and 
CH2Cl2 (40 mL) were added. The layers were separated and the aqueous phase extracted with CH2Cl2 
(4 × 30 mL). The combined organics were washed with brine (30 mL), dried over MgSO4, filtered and 
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concentrated in vacuo. The crude residue was purified by column chromatography, eluting with 90:10 
petrol/EtOAc (+0.1% AcOH), to afford the product (2.30 g, 92%) as a white solid. 
įH (400 MHz, CDCl3) 3.41 (t, 2H, J 6.9 Hz, CH2Br), 2.35 (t, 2H, J 7.5 Hz, CH2CO2H), 1.80±1.90 (m, 
2H, CH2CH2Br), 1.59±1.68 (m, 2H, CH2CH2CO2H), 1.25±1.48 (m, 22H, 11 × CH2). 
įC (101 MHz, CDCl3) 178.6, 34.2, 33.9, 33.0, 29.8, 29.7, 29.6, 29.4, 29.2, 28.9, 28.3, 24.8. 
LR-MS (EI+) 337.0 ([M(81Br)+H]+), 335.0 ([M(79Br)+H]+), 317.0 ([M(81Br)-H2O+H]+), 315.0 
([M(79Br)-H2O+H]+), 257.1 ([M-Br+H]+), 237.1 ([M-Br-H2O+H]+). 
HR-MS calcd for C16H3079BrOǦ ([M-H]Ǧ)  333.1435, found 333.1430. 
ȣmax (thin film, cm-1) 3034, 2917, 2850, 1696 
Mp 72-74 °C (lit. 71 °C)(11) 
Preparation of 16-azidohexadecanoic acid 23(6) 
 
 Reaction performed under a N2 atmosphere 
 NaN3 (582 mg, 8.96 mmol) was added to a solution of bromide 18 (500 mg, 1.49 mmol) in 
DMF (6 mL). The reaction was stirred at 80 °C for 40 h before being cooled to room temperature. A 
1:1 mixture  of EtOAc/H2O (20 mL) was added, the layers separated and the aqueous phase 
extracted with EtOAc (3 × 10 mL). The combined organics were washed with brine (10 mL), dried 
over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by column 
chromatography, eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (402 mg, 
91%) as a white solid. 
įH (400 MHz, CDCl3) 3.25 (t, 2H, J 7.0 Hz, CH2N3), 2.34 (t, 2H, J 7.5 Hz, CH2CO2H), 1.55±1.67 (m, 
4H, CH2CH2N3, CH2CH2CO2H), 1.24±1.40 (m, 22H, 11 × CH2). 
įC (101 MHz, CDCl3) 180.0, 51.7, 34.2, 29.8, 29.7, 29.7, 29.6, 29.6, 29.4, 29.3, 29.3, 29.2, 29.2, 29.0, 
26.9, 24.8. 
LR-MS (ES-) 268.2 ([M-N2-H]Ǧ), 296.2 ([M-H]Ǧ). 
HR-MS calcd for C16H32NO2+ ([M-N2+H]+) 270.2440, found 270.2433. 
ȣmax (thin film, cm-1) 3014, 2915, 2848, 2103, 1701. 
Mp 48±50 °C 
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Preparation of 18-(trimethylsilyl)octadec-17-ynoic acid 28 
 
 Reaction performed under a N2 atmosphere. 
 
nBuLi (2.09 M, 3.6 mL, 7.46 mmol) was added drop-wise to a solution of 
(trimethylsilyl)acetylene (773 mg, 1.05 mL, 7.46 mmol) in THF (4.6 mL) at -78 °C. The reaction was 
stirred at -78 °C for 1 h before DMPU (8.3 mL) was added and the reaction stirred for a further 
30 min. A solution of bromide 18 (500 mg, 1.49 mmol) in THF (16.7 mL) was added drop-wise and 
the reaction stirred at room temperature for 48 h. Upon completion, the reaction was quenched with 
HCl (20 mL of a 1 M solution). The layers were separated and the aqueous phase extracted with Et2O 
(4 × 20 mL). The combined organics were washed with brine (3 × 20 mL), dried over MgSO4, filtered 
and concentrated in vacuo. The crude residue was purified by column chromatography, eluting with 
90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (288 mg, 55%) as a white solid. 
įH (400 MHz, CDCl3) 2.34 (t, 2H, J 7.5 Hz, CH2CO2H), 2.20 (t, 2H, J 7.2 Hz, CH2CŁ&6L±1.69 
(m, 2H, CH2CH2CO2H), 1.46±1.56 (m, 2H, CH2CH2CŁ&6L4±1.40 (m, 22H, 11 × CH2), 0.14 (s, 
9H, Si(CH3)3). 
įC (101 MHz, CDCl3) 179.8, 108.0, 84.4, 34.1, 29.8, 29.7, 29.6, 29.6, 29.4, 29.2, 29.0, 28.8, 24.8, 
20.0, 0.3. 
LR-MS (ES-) 351.3 ([M-H]Ǧ). 
HR-MS calcd for C21H39O2SiǦ ([M-H]Ǧ) 251.2725, found 351.2718. 
ȣmax (thin film, cm-1) 2937, 2919, 2850, 2178, 1714, 1699. 
Mp 50±53 °C 
Preparation of octadec-17-ynoic acid 31(14) 
 
 K2CO3 (223 mg, 1.61 mmol) was added to a solution of TMS-alkyne 28 (228 mg, 0.65 mmol) 
in methanol (6.5 mL) at room temperature. The reaction was stirred at room temperature for 20 h 
before the solvent was evaporated in vacuo. The residue was dissolved in EtOAc (15 mL) and HCl 
(15 mL of a 1 M aqueous solution) added. The layers were separated and the aqueous phase extracted 
with EtOAc (3 × 20 mL). The combined organics were washed with brine (20 mL), dried over 
MgSO4, filtered and concentrated in vacuo. The crude residue was purified by column 
chromatography, eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (161 mg, 
89%) as a white solid. 
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įH (400 MHz, CDCl3) 2.34 (t, 2H, J 7.5 Hz, CH2CO2H), 2.18 (td, 2H, J 7.1 Hz, 4J 2.6 Hz, CH2&Ł&+
1.93 (t, 1H, 4J 2.6 +]&Ł&H), 1.59±1.67 (m, 2H, CH2CH2CO2H), 1.48±1.56 (m, 2H, CH2CH2CŁ&+
1.24±1.44 (m, 22H, 11 × CH2). 
įC (101 MHz, CDCl3) 180.1, 85.0, 68.2, 34.2, 29.8, 29.7, 29.6, 29.6, 29.4, 29.3, 29.2, 28.9, 28.7, 28.4, 
18.5. 
LR-MS (ES-) 279.2 ([M-H]Ǧ). 
HR-MS calcd for C18H31O2Ǧ ([M-H]Ǧ) 279.2330, found 279.2331. 
ȣmax (thin film, cm-1) 3284, 3042, 2917, 2850, 2115, 1694. 
Mp 70±72 °C 
Preparation of 1,18-octadecanediol 9(15-17) 
Method A 
 
 Reaction performed under a N2 atmosphere. 
 Solid LiAlH4 (1.21 g, 31.8 mmol) was added to a solution of 1,18-octadecanedioic acid 
(5.00 g, 15.9 mmol) in THF (160 mL) at 0 °C. The reaction was allowed to warm to room temperature 
and stirred at room temperature for 20 h. Upon completion, wet NaSO4 was added portion-wise until 
the grey suspension turned white. The suspension was stirred at room temperature until the white 
solid was free-flowing, and solid MgSO4 was added. The reaction was filtered and the filter cake 
washed with Et2O (5 × 50 mL). The solvent was evaporated in vacuo to afford the product (2.26 g, 
50%) as a white solid. 
Method B 
 
 Reaction performed under a N2 atmosphere. 
 Solid LiAlH4 (1.44 g, 37.96 mmol) was added to a vigorously stirred solution of dimethyl 
octadecanedioate (5.00 g, 14.9 mmol) at room temperature. The reaction was heated to reflux and 
stirred at reflux for 20 h. Upon completion, the reaction was cooled to room temperature and wet 
NaSO4 was added portion-wise until the grey suspension turned white. The suspension was stirred at 
room temperature until the white solid was free-flowing, and solid MgSO4 was added. The reaction 
was filtered and the filter cake washed with Et2O (5 × 50 mL). The solvent was evaporated in vacuo 
to afford the product (4.15 g, 99%) as a white solid. 
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įH (600 MHz, DMSO-d6) 4.30 (t, 2H, J 5.1 Hz, 2 × OH), 3.34±3.39 (m, 4H, 2 × CH2OH), 1.35±1.43 
(m, 4H, 2 × CH2CH2OH), 1.23 (app. br. s., 28H, 14 × CH2). 
įC (151 MHz, DMSO-d6) 60.6, 32.3, 28.8, 28.8, 28.7, 25.3. 
LR-MS (MALDI-TOF) 293.3 ([M+Li]+), 309.3 ([M+Na]+). 
HR-MS calcd for C18H39O2+ ([M+H]+) 287.2945, found 287.2946. 
ȣmax (thin film, cm-1) 3416, 3353, 2919, 2891. 
Mp 103±106 °C (lit. 98±99 °C)(16, 17) 
Preparation of 18-bromooctadecan-1-ol 14(12) 
 
 HBr (48% in H2O, 21 mL) was added to a suspension of diol 9 (2.26 g, 7.9 mmol) in 
cyclohexane (21 mL). The biphasic mixture was heated to reflux for 10 h before being cooled to room 
temperature. The layers were separated and the aqueous phase extracted with CH2Cl2 (4 × 20 mL). 
The combined organics were washed with NaHCO3 (4 × 20 mL of a saturated aqueous solution), brine 
(20 mL), dried over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by 
column chromatography, eluting with 95:5 petrol/EtOAc then 70:30 petrol/EtOAc, to afford the 
product (1.65 g, 60%) as a pale yellow solid. 
įH (400 MHz, CDCl3) 3.64 (t, 2H, J 6.6 Hz, CH2OH), 3.40 (t, 2H, J 6.9 Hz, CH2Br), 1.81±1.89 (m, 
2H, CH2CH2Br), 1.53±1.60 (m, 2H, CH2CH2OH), 1.25±1.46 (m, 28H, 14 × CH2). 
įC (101 MHz, CDCl3) 63.3, 34.2, 33.0, 33.0, 29.8, 29.8, 29.7, 29.6, 28.9, 28.3, 25.9. 
LR-MS (ES+) 332.5 ([M(81Br)-H2O+H]+), 330.5 ([M(79Br)-H2O+H]+). 
HR-MS calcd for C18H4179BrON+ ([M+NH4]+) 366.2366, found 336.2368. 
ȣmax (thin film, cm-1) 3274, 2917, 2850. 
Mp 59±61 °C (lit. 60±62 °C)(12) 
Preparation of 18-bromooctadecanoic acid 19(12, 18) 
 
 CrO3 (1.42 g, 14.2 mmol) was dissolved in concentrated H2SO4 (3.5 mL). Cold H2O (7.9 mL) 
was added slowly and the solution stirred at room temperature for 10 min. The resulting solution was 
added drop-wise to a solution of alcohol 14 (1.65 g, 4.73 mmol) in acetone (120 mL). The reaction 
was stirred at room temperature for 20 h before being H2O (60 mL) and CH2Cl2 (40 mL) were added. 
The layers were separated and the aqueous phase extracted with CH2Cl2 (4 × 20 mL). The combined 
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organics were washed with brine (20 mL), dried over MgSO4, filtered and concentrated in vacuo. The 
crude residue was purified by column chromatography, eluting with 90:10 petrol/EtOAc (+0.1% 
AcOH), to afford the product (1.43 g, 83%) as a white solid. 
įH (400 MHz, CDCl3) 3.41 (t, 2H, J 6.9 Hz, CH2Br), 2.35 (t, 2H, J 7.5 Hz, CH2CO2H), 1.81±1.90 (m, 
2H, CH2CH2Br), 1.59±1.68 (m, 2H, CH2CH2CO2H), 1.25±1.46 (m, 26H, 13 × CH2). 
įC (101 MHz, CDCl3) 179.6, 34.2, 34.1, 33.0, 29.8, 29.7, 29.7, 29.6, 29.4, 29.2, 28.9, 28.3, 24.8. 
LR-MS (EI+) 365.0 ([M(81Br)+H]+), 363.0 ([M(79Br)+H]+), 347.0 ([M(81Br)-H2O+H]+), 345.0 
([M(79Br)-H2O+H]+), 284.0 ([M-Br+H]+), 265.1 ([M-Br-H2O+H]+). 
HR-MS calcd for C18H3479BrO2Ǧ ([M-H]Ǧ) 361.1748, found 361.1741. 
ȣmax (thin film, cm-1) 3034, 2915, 2850, 1696 
Mp 77±80 °C (lit. 80 °C)(18) 
Preparation of 18-azidooctadecanoic acid 24 
 
 Reaction performed under a N2 atmosphere 
 NaN3 (537 mg, 8.3 mmol) was added to a solution of bromide 19 (500 mg, 1.38 mmol) in 
DMF (5.5 mL). The reaction was stirred at 80 °C for 40 h before being cooled to room temperature. A 
1:1 mixture  of EtOAc/H2O (30 mL) was added, the layers separated and the aqueous phase 
extracted with EtOAc (3 × 10 mL). The combined organics were washed with brine (10 mL), dried 
over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by column 
chromatography, eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (403 mg, 
90%) as a white solid. 
įH (400 MHz, CDCl3) 3.25 (t, 2H, J 7.0 Hz, CH2N3), 2.34 (t, 2H, J 7.5 Hz, CH2CO2H), 1.55±1.67 (m, 
4H, CH2CH2N3, CH2CH2CO2H), 1.25±1.39 (m, 26H, 13 × CH2). 
įC (101 MHz, CDCl3) 180.1, 51.6, 34.2, 29.8, 29.7, 29.7, 29.6, 29.6, 29.4, 29.4, 29.3, 29.2, 29.0, 26.7, 
24.8. 
LR-MS (ES-) 296.3 ([M-N2-H]Ǧ), 324.1 ([M-H]Ǧ). 
HR-MS calcd for C18H34N3O2Ǧ ([M-H]Ǧ) 324.2657, found 324.2649. 
ȣmax (thin film, cm-1) 3040, 2915, 2850, 2098, 1696. 
Mp 56±58 °C 
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Preparation of 20-(trimethylsilyl)icos-19-ynoic acid 29 
 
 Reaction performed under a N2 atmosphere. 
 
nBuLi (2.00 M, 6.9 mL, 13.8 mmol) was added drop-wise to a solution of 
(trimethylsilyl)acetylene (1.36 g, 1.95 mL, 13.8 mmol) in THF (20 mL) at -78 °C. The reaction was 
stirred at -78 °C for 1 h before DMPU (15.3 mL) was added and the reaction stirred for a further 
30 min. A solution of bromide 19 (500 mg, 1.38 mmol) in THF (14.5 mL) was added drop-wise and 
the reaction stirred at room temperature for 48 h. Upon completion, the reaction was quenched with 
HCl (20 mL of a 1 M solution). The layers were separated and the aqueous phase extracted with Et2O 
(4 × 20 mL). The combined organics were washed with brine (3 × 20 mL), dried over MgSO4, filtered 
and concentrated in vacuo. The crude residue was purified by column chromatography, eluting with 
90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (305 mg, 58%) as a white solid. 
įH (400 MHz, CDCl3) 2.34 (t, 2H, J 7.5 Hz, CH2CO2H), 2.21 (t, 2H, J 7.2 Hz, CH2&Ł&6L9±1.67 
(m, 2H, CH2CH2CO2H), 1.47±1.55 (m, 2H, CH2CH2CŁ&6L5±1.39 (m, 26H, 13 × CH2), 0.14 (s, 
9H, Si(CH3)3). 
įC (101 MHz, CDCl3) 179.8, 108.0, 84.4, 34.1, 29.8, 29.7, 29.6, 29.6, 29.4, 29.2, 29.0, 28.8, 24.8, 
20.0, 0.3. 
LR-MS (ES-) 379.3 ([M-+@Ǧ). 
HR-MS calcd for C23H43O2Ǧ ([M-H]Ǧ) 379.3038, found 379.3030. 
ȣmax (thin film, cm-1) 2937, 2917, 2850, 2178, 1714, 1699. 
Mp 58±60 °C 
Preparation of icos-19-ynoic acid 32 
 
 K2CO3 (233 mg, 1.69 mmol) was added to a solution of TMS-alkyne 29 (257 mg, 0.67 mmol) 
in methanol (6.7 mL) at room temperature. The reaction was stirred at room temperature for 20 h 
before the solvent was evaporated in vacuo. The residue was dissolved in EtOAc (15 mL) and HCl 
(15 mL of a 1 M aqueous solution) added. The layers were separated and the aqueous phase extracted 
with EtOAc (3 × 20 mL). The combined organics were washed with brine (20 mL), dried over 
MgSO4, filtered and concentrated in vacuo. The crude residue was purified by column 
chromatography, eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (134 mg, 
65%) as a white solid. 
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įH (400 MHz, CDCl3) 2.34 (t, 2H, J 7.5 Hz, CH2CO2H), 2.18 (td, 2H, J 7.1 Hz, 4J 2.6 Hz, CH2&Ł&+
1.93 (t, 1H, 4J +]&Ł&H), 1.58±1.68 (m, 2H, CH2CH2CO2H), 1.48±1.56 (m, 2H, CH2CH2CŁ&+
1.24±1.43 (m, 26H, 13 × CH2). 
įC (101 MHz, CDCl3) 179.9, 85.0, 68.2, 34.1, 29.8, 29.7, 29.7, 29.6, 29.4, 29.3, 29.2, 28.9, 28.7, 24.8, 
18.5. 
LR-MS (ES-) 307.2 ([M-H]Ǧ). 
HR-MS calcd for C20H35O2Ǧ ([M-H]Ǧ) 307.2643, found 307.2636. 
ȣmax (thin film, cm-1) 3282, 2915, 2850, 2115, 1694. 
Mp 76±78 °C 
 
Preparation of 1,20-icosanediol 10(19-22) 
Method A 
 
 Reaction performed under a N2 atmosphere. 
 BH3.THF (1 M, 8.8 mL, 8.8 mmol) was added to a solution of icosanedioic acid (1.00 g, 
2.92 mmol) in THF (58 mL). The reaction was heated to 50 °C for 24 h before additional BH3.THF 
(1 M, 2.9 mL, 2.9 mmol) was added. The reaction was heated for a further 24 h before being cooled to 
0 °C, quenched with MeOH (20 mL) and stirred for 30 min. HCl (20 mL of a 2 M aqueous solution) 
was added and the mixture stirred for 1 h. The solvent was evaporated in vacuo and the remaining 
aqueous phase extracted with CHCl3 (3 × 30 mL). The combined organic phase was washed with H2O 
(30 mL), brine (30 mL), dried over MgSO4, filtered and concentrated in vacuo to afford the product 
(724 mg, 79%) as white solid. 
Method B 
 
 Reaction performed under a N2 atmosphere. 
 Solid LiAlH4 (1.44 g, 37.96 mmol) was added to a vigorously stirred solution of icosanedioic 
acid (5.00 g, 14.6 mmol) at room temperature. The reaction was heated to reflux and stirred at reflux 
for 20 h. Upon completion, the reaction was cooled to room temperature and wet NaSO4 was added 
portion-wise until the grey suspension turned white. The suspension was stirred at room temperature 
until the white solid was free-flowing, and solid MgSO4 was added. The reaction was filtered and the 
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filter cake washed with Et2O (5 × 50 mL). The solvent was evaporated in vacuo to afford the product 
(4.35 g, 95%) as a white solid. 
įH (600 MHz, DMSO-d6) 3.38 (t, 4H, J 6.5 Hz, 2 × CH2OH), 1.37±1.45 (m, 4H, 2 × CH2CH2OH), 
1.23 (app. br. s., 32H, 16 × CH2). 
įC (151 MHz, DMSO-d6) 60.6, 32.3, 28.8, 28.7, 28.7, 25.3. 
LR-MS (MALDI-TOF) 337.3 ([M+Na]+). 
HR-MS calcd for C20H43O2+ ([M+H]+) 315.3258, found 315.3259. 
ȣmax (thin film, cm-1) 3252, 2915, 2848. 
Mp 103±105 °C (lit. 102±105 °C)(20) 
 
Preparation of 20-bromoicosan-1-ol 15 
 
 HBr (48% in H2O, 36 mL) was added to a suspension of diol 10 (4.35 g, 13.6 mmol) in 
cyclohexane (86 mL). The biphasic mixture was heated to reflux for 10 h before being cooled to room 
temperature. The layers were separated and the aqueous phase extracted with CH2Cl2 (4 × 50 mL). 
The combined organics were washed with NaHCO3 (4 × 30 mL of a saturated aqueous solution), brine 
(30 mL), dried over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by 
column chromatography, eluting with 95:5 petrol/EtOAc then 70:30 petrol/EtOAc, to afford the 
product (2.94 g, 57%) as a pale yellow solid. 
įH (400 MHz, CDCl3) 3.64 (t, 2H, J 6.6 Hz, CH2OH), 3.41 (t, 2H, J 6.9 Hz, CH2Br), 1.81±1.89 (m, 
2H, CH2CH2Br), 1.53±1.59 (m, 2H, CH2CH2OH), 1.25±1.45 (m, 32H, 16 × CH2). 
įC (101 MHz, CDCl3) 63.3, 34.2, 33.0, 33.0, 29.8, 29.8, 29.7, 29.6, 28.9, 28.3, 25.9. 
LR-MS (EI+) 376.4 ([M(81Br)+H]+), 374.4 ([M(79Br)+H]+), 361.1 ([M(81Br)-H2O+H]+), 359.1 
([M(79Br)-H2O+H]+,), 296.6 ([M-Br+H]+). 
HR-MS calcd for C20H4079Br+ ([M-H2O+H]+) 359.2313, found 359.2313. 
ȣmax (thin film, cm-1) 3270, 2915, 2846. 
Mp 66±68 °C 
Preparation of 20-bromoicosanoic acid 20 
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 CrO3 (3.12 g, 31.2 mmol) was dissolved in concentrated H2SO4 (5.7 mL). Cold H2O (13 mL) 
was added slowly and the solution stirred at room temperature for 10 min. The resulting solution was 
added drop-wise to a solution of alcohol 15 (2.94 g, 7.8 mmol) in acetone (195 mL). The reaction was 
stirred at room temperature for 20 h before being H2O (100 mL) and CH2Cl2 (50 mL) were added. The 
layers were separated and the aqueous phase extracted with CH2Cl2 (4 × 50 mL). The combined 
organics were washed with brine (50 mL), dried over MgSO4, filtered and concentrated in vacuo. The 
crude residue was purified by column chromatography, eluting with 90:10 petrol/EtOAc (+0.1% 
AcOH), to afford the product (2.53 g, 83%) as a white solid. 
įH (400 MHz, CDCl3) 3.41 (t, 2H, J 6.9 Hz, CH2Br), 2.35 (t, 2H, J 7.5 Hz, CH2CO2H), 1.81±1.90 (m, 
2H, CH2CH2Br), 1.59±1.68 (m, 2H, CH2CH2CO2H), 1.25±1.46 (m, 30H, 15 × CH2). 
įC (101 MHz, CDCl3) 178.9, 34.2, 34.0, 33.0, 29.8, 29.7, 29.6, 29.4, 29.2, 28.9, 28.3, 24.8. 
LR-MS (EI+) 393.0 ([M(81Br)+H]+), 391.0 ([M(79Br)+H]+), 375.0 ([M(81Br)-H2O+H]+), 373.0 
([M(79Br)-H2O+H]+), 312.0 ([M-Br+H]+), 293.1 ([M-Br-H2O+H]+). 
HR-MS calcd for C20H3879BrOǦ ([M-H]Ǧ) 389.2061, found 389.2057. 
ȣmax (thin film, cm-1) 2914, 2848, 1693. 
Mp 81±83 °C 
Preparation of 20-azidoicosanoic acid 25 
 
 Reaction performed under a N2 atmosphere 
 NaN3 (499 mg, 7.7 mmol) was added to a solution of bromide 20 (500 mg, 1.28 mmol) in 
DMF (5 mL). The reaction was stirred at 80 °C for 40 h before being cooled to room temperature. A 
1:1 mixture  of EtOAc/H2O (30 mL) was added, the layers separated and the aqueous phase 
extracted with EtOAc (3 × 15 mL). The combined organics were washed with brine (15 mL), dried 
over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by column 
chromatography, eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product (425 mg, 
94%) as a white solid. 
įH (400 MHz, CDCl3) 3.25 (t, 2H, J 7.0 Hz, CH2N3), 2.35 (t, 2H, J 7.5 Hz, CH2CO2H), 1.55±1.67 (m, 
4H, CH2CH2N3, CH2CH2CO2H), 1.25±1.39 (m, 30H, 15 × CH2). 
įC (101 MHz, CDCl3) 179.6, 51.7, 34.1, 29.8, 29.8, 29.7, 29.7, 29.6, 29.6, 29.4, 29.3, 29.2, 29.0, 26.9, 
24.8. 
LR-MS (ES-) 324.3 ([M-N2-+@Ǧ), 352.3 ([M-+@Ǧ). 
HR-MS calcd for C20H38N3O2Ǧ ([M-H]Ǧ) 352.2970, found 352.2963. 
ȣmax (thin film, cm-1) 3012, 2915, 2848, 2111, 1701. 
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Mp 63±65 °C 
Preparation of 1,22-docosanediol 11(23) 
Method A 
 
 Reaction performed under a N2 atmosphere. 
 BH3.THF (1 M, 8.2 mL, 8.2 mmol) was added to a solution of docosanedioic acid (1.00 g, 
2.70 mmol) in THF (51 mL). The reaction was heated to 50 °C for 24 h before additional BH3.THF 
(1 M, 2.7 mL, 2.7 mmol) was added. The reaction was heated for a further 24 h before being cooled to 
0 °C, quenched with MeOH (20 mL) and stirred for 30 min. HCl (20 mL of a 2 M aqueous solution) 
was added and the mixture stirred for 1 h. The solvent was evaporated in vacuo and the remaining 
aqueous phase extracted with CHCl3 (3 × 30 mL). The combined organic phase was washed with H2O 
(30 mL), brine (30 mL), dried over MgSO4, filtered and concentrated in vacuo to afford the product 
(974 mg, 100%) as white solid. 
Method B 
 
 Reaction performed under a N2 atmosphere. 
 Solid LiAlH4 (1.36 g, 35.9 mmol) was added to a vigorously stirred solution of docosanedioic 
acid (5.12 g, 13.8 mmol) at room temperature. The reaction was heated to reflux and stirred at reflux 
for 20 h. Upon completion, the reaction was cooled to room temperature and wet NaSO4 was added 
portion-wise until the grey suspension turned white. The suspension was stirred at room temperature 
until the white solid was free-flowing, and solid MgSO4 was added. The reaction was filtered and the 
filter cake washed with Et2O (5 × 50 mL). The solvent was evaporated in vacuo to afford the product 
(4.30 g, 91%) as a white solid. 
įH (600 MHz, DMSO-d6) 4.17 (t, 2H, J 5.1 Hz, 2 × OH), 3.36±3.40 (m, 4H, 2 × CH2OH), 1.38±1.44 
(m, 4H, 2 × CH2CH2OH), 1.25 (app. br. s., 36H, 18 × CH2). 
įC (151 MHz, DMSO-d6) 60.6, 32.3, 28.8, 28.8, 28.7, 25.3. 
LR-MS (MALDI-TOF) 365.4 ([M+Na]+). 
HR-MS calcd for C22H47O2+ ([M+H]+) 343.3571, found 343.3574. 
ȣmax (thin film, cm-1) 3255, 2915, 2848. 
Mp 98±100 °C (lit. 96±98 °C)(23) 
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Preparation of 22-bromodocosan-1-ol 16(24) 
 
 HBr (48% in H2O, 32 mL) was added to a suspension of diol 11 (4.16 g, 12.2 mmol) in 
cyclohexane (64 mL). The biphasic mixture was heated to reflux for 10 h before being cooled to room 
temperature. The layers were separated and the aqueous phase extracted with CH2Cl2 (4 × 50 mL). 
The combined organics were washed with NaHCO3 (4 × 30 mL of a saturated aqueous solution), brine 
(30 mL), dried over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by 
column chromatography, eluting with 95:5 petrol/EtOAc then 70:30 petrol/EtOAc, to afford the 
product (2.65 g, 54%) as a pale yellow solid. 
įH (400 MHz, CDCl3) 3.64 (t, 2H, J 6.6 Hz, CH2OH), 3.40 (t, 2H, J 6.9 Hz, CH2Br), 1.81±1.89 (m, 
2H, CH2CH2Br), 1.53±1.60 (m, 2H, CH2CH2OH), 1.25±1.44 (m, 36H, 18 × CH2). 
įC (101 MHz, CDCl3) 63.3, 34.2, 33.0, 33.0, 29.8, 29.8, 29.7, 29.6, 28.9, 28.3, 25.9. 
LR-MS (EI+) 405.5 ([M(81Br)+H]+), 403.5 ([M(79Br)+H]+), 388.5 ([M(81Br)-H2O+H]+), 386.5 
([M(79Br)-H2O+H]+), 324.4 ([M-Br+H]+). 
HR-MS calcd for C22H4979BrON ([M+NH4]+) 422.2992, found 422.2990. 
ȣmax (thin film, cm-1) 3276, 2915, 2846. 
Mp 66±68 °C (lit. 72 °C)(24) 
Preparation of 22-bromodocosanoic acid 21 
 
 CrO3 (696 mg, 6.96 mmol) was dissolved in concentrated H2SO4 (1.3 mL). Cold H2O 
(2.9 mL) was added slowly and the solution stirred at room temperature for 10 min. The resulting 
solution was added drop-wise to a solution of alcohol 16 (703 mg, 1.74 mmol) in acetone/CH2Cl2 
(3:1, 65 mL). The reaction was stirred at room temperature for 20 h before being H2O (50 mL) and 
CH2Cl2 (30 mL) were added. The layers were separated and the aqueous phase extracted with CH2Cl2 
(4 × 30 mL). The combined organics were washed with brine (30 mL), dried over MgSO4, filtered and 
concentrated in vacuo. The crude residue was purified by column chromatography, eluting with 90:10 
petrol/EtOAc (+0.1% AcOH), to afford the product (522 mg, 72%) as a white solid. 
įH (400 MHz, CDCl3) 3.40 (t, 2H, J 6.9 Hz, CH2Br), 2.35 (t, 2H, J 7.5 Hz, CH2CO2H), 1.81±1.90 (m, 
2H, CH2CH2Br), 1.59±1.68 (m, 2H, CH2CH2CO2H), 1.25±1.44 (m, 34H, 17 × CH2). 
įC (101 MHz, CDCl3) 179.4, 34.2, 34.1, 33.0, 29.8, 29.7, 29.6, 29.4, 29.2, 28.9, 28.3, 24.8. 
LR-MS (EI+) 421.0 ([M(81Br)+H]+), 419.0 ([M(79Br)+H]+), 393.0 ([M(81Br)-H2O+H]+), 391.0 
([M(79Br)-H2O+H]+), 341.1 ([M-Br+H]+), 293.1 ([M-Br-H2O+H]+). 
 19 
 
HR-MS calcd for C22H4279BrO2Ǧ ([M-+@Ǧ) 417.2374, found 417.2368. 
ȣmax (thin film, cm-1) 2913, 2846, 1693. 
Mp 78±80 °C 
Preparation of 22-azidodocosanoic acid 26 
 
 Reaction performed under a N2 atmosphere 
 NaN3 (195 mg, 3.0 mmol) was added to a solution of bromide 21 (208 mg, 0.5 mmol) in 
DMF (2 mL). The reaction was stirred at 80 °C for 40 h before being cooled to room temperature. A 
1:1 mixture of EtOAc/H2O (20 mL) was added, the layers separated and the aqueous phase extracted 
with EtOAc (3 × 10 mL) and CH2Cl2 (10 mL). The combined organics were washed with brine 
(15 mL), dried over MgSO4, filtered and concentrated in vacuo. The crude residue was purified by 
column chromatography, eluting with 90:10 petrol/EtOAc (+0.1% AcOH), to afford the product 
(176 mg, 92%) as a white solid. 
įH (400 MHz, CDCl3) 3.25 (t, 2H, J 7.0 Hz, CH2N3), 2.34 (t, 2H, J 7.5 Hz, CH2CO2H), 1.56±1.67 (m, 
4H, CH2CH2N3, CH2CH2CO2H), 1.25±1.37 (m, 34H, 17 × CH2). 
įC (101 MHz, CDCl3) 179.9, 51.7, 34.1, 29.8, 29.7, 29.7, 29.6, 29.6, 29.4, 29.3, 29.3, 29.2, 29.0, 26.9, 
24.8. 
LR-MS (ES-) 352.3 ([M-N2-+@Ǧ), 380.3 ([M-H]Ǧ).  
HR-MS calcd for C22H42N3O2Ǧ ([M-+@Ǧ) 380.3283, found 380.3275. 
ȣmax (thin film, cm-1) 2913, 2846, 2095, 1693. 
Mp 71±73 °C 
 20 
 
14-Azidotetradecanoic acid 22 1H NMR (400 MHz, CDCl3) 
 
 21 
 
14-Azidotetradecanoic acid 22 13C NMR (101 MHz, CDCl3) 
 
 22 
 
16-Azidohexadecanoic acid 23 1H NMR (400 MHz, CDCl3) 
 
 23 
 
16-Azidohexadecanoic acid 23 13C NMR (101 MHz, CDCl3) 
 
 24 
 
18-Azidooctadecanoic acid 24 1H NMR (400 MHz, CDCl3) 
 
 25 
 
18-Azidooctadecanoic acid 24 13C NMR (101 MHz, CDCl3) 
 
 26 
 
20-Azidoicoscanoic acid 25 1H NMR (400 MHz, CDCl3) 
 
 27 
 
20-Azidoicoscanoic acid 25 13C NMR (101 MHz, CDCl3) 
 
 28 
 
22-Azidodocoscanoic acid 26 1H NMR (400 MHz, CDCl3) 
 
 29 
 
22-Azidodcoscanoic acid 26 13C NMR (101 MHz, CDCl3) 
 
 30 
 
Hexadec-15-ynoic acid 30 1H NMR (400 MHz, CDCl3) 
 
 31 
 
Hexadec-15-ynoic acid 30 13C NMR (101 MHz, CDCl3) 
 
 32 
 
Octadec-17-ynoic acid 31 1H NMR (400 MHz, CDCl3) 
 
 33 
 
Octadec-17-ynoic acid 31 13C NMR (101 MHz, CDCl3) 
 
 34 
 
Icos-19-ynoic acid 32 1H NMR (400 MHz, CDCl3) 
 
 35 
 
Icos-19-ynoic acid 32 13C NMR (101 MHz, CDCl3) 
 36 
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Acyl-CoA MRM Transition Collision 
Energy (eV) 
Declustering 
Potential (eV) 
Dwell 
Time (ms) 
Response  
factor 
14:0 976o471 40 40 500 2.25 
16:0 1006o499 40 40 500 2.38 
16:1 1004o497 40 40 500 2.3 
17:0 1020o513 40 40 100 2.32 
18:0 1034o527 45 40 250 2.62 
18:1 1032o525 45 40 250 2.5 
18:2 1030o523 50 45 500 2.4 
20:0 1062o555 50 45 500 2.48 
20:2 1058o551 50 45 500 2.3 
20:4 1054o547 50 45 250 2.23 
20:5 1052o545 55 45 500 2.2 
22:0 1090o583 50 45 500 2.2 
22:4 1082o575 55 45 500 2.1 
22:5 1080o573 55 45 500 2.1 
22:6 1078o571 50 45 500 2.1 
C14:0-azide 1019o512 40 40 500 2.3 
C16:0-azide 1047o540 40 40 500 2.3 
C16:1-azide 1045o538 40 40 500 2.3 
C18:0-azide 1075o568 45 40 500 2.3 
C18:1-azide 1073o566 45 40 500 2.2 
C18:2-azide 1071o564 45 40 500 2.1 
C20:0-azide 1113o596 50 45 500 2.3 
C20:1-azide 1111o594 50 45 500 2.3 
C22:0-azide 1141o624 50 45 500 2.2 
 
 
Table 1. MRM Transitions: 
Multiple reaction monitoring transitions were based upon optimized fragmentation in positive ion mode. 
Interface temp 30 C, Nanomate: gas pressure 0.5 psi, Tip voltage 1.25-1.3kV, EP 8, CXP 12. 
 
1 Resp Factor1 (106 cpm/pmole) are based upon standard curve point (1000, 500, 100, 10, 5, 2.5 and 1 
pmole(s)) has its own response in terms of number of specific ions observed by the mass spectrometer 
under those specific conditions. Values in blue represent estimates in the absence of actual standards 
and similar related response factors observed previously (doi: 10.1194/jlr.D800001-JLR200)) 
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Supplementary Figure 1: S-acylaƟon of wild-type and inacƟve zDHHC enzymes by C16:0- azides.  
HEK293T cells transfected with HA-tagged wild-type or mutant zDHHC enzyme constructs containing a cysteine-
to-serine mutaƟon of the catalyƟc DHHC cysteine residue. Cells were then incubated with C16:0 faƩy acid azides 
for 4 h at 37 ºC. FaƩy acid azides were then labelled by click chemistry using an alkyne-800 infrared dye. Isolated 
proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes. RepresentaƟve click signals 
and western blots are shown. PosiƟon of molecular weight markers are shown on the leŌ. Arrowheads indicate 
the zDHHC bands that incorporate label. 
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Supplementary Figure 2: S-acylaƟon of EGFP-Cysteine-string protein by diīerent zDHHC enzymes. 
HEK293T cells were transfected with EGFP-CSP together with pEF-BOS-HA (vector), HA-zDHHC3 or HA-zDHHC7. 
Cells were then incubated with C14:0, C16:0 or C18:0 faƩy acid azides as indicated for 4 h at 37 ºC. FaƩy acid 
azides were labelled by click chemistry using an alkyne-800 infrared dye. Isolated proteins were resolved by SDS-
PAGE and transferred to nitrocellulose membranes. RepresentaƟve click signals and western blots are shown. 
PosiƟon of molecular weight markers are shown on the leŌ. Note that CSP migrates as two bands, the upper 
band (arrowhead) is S-acylated, whereas the lower band is non-acylated. 
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Supplementary Figure 3: S-acylaƟon proĮles of Danio rerio zDHHC3 and zDHHC7 by faƩy-acid azides.  
(A) HEK293T cells transfected with HA-tagged zDHHC3 or zDHHC7 from Danio rerio were incubated with C14:0, 
C16:0 or C18:0 faƩy acid azides for 4 h at 37 ºC. FaƩy acid azides were then labelled by click chemistry using an 
alkyne-800 infrared dye. Isolated proteins were resolved by SDS-PAGE and transferred to nitrocellulose 
membranes. RepresentaƟve click signals and western blots and quanƟĮed data (mean ± SEM) are shown. n = 5; 
ns = not signiĮcant. (B) HEK293T cells were transfected with EGFP-SNAP25B together with either pEF-BOS-HA 
(vector control), zDHHC3 or zDHHC7 from Danio rerio, or mouse zDHHC7. Cells were then incubated with C14:0, 
C16:0 or C18:0 faƩy acid azides for 4 h at 37 ºC, and faƩy acid azides were then labelled by click chemistry using 
an alkyne-800 infrared dye. Isolated proteins were resolved by SDS-PAGE and transferred to nitrocellulose 
membranes. RepresentaƟve click signals and western blots are shown.  
